These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9529682)

  • 1. Mast cells in clinical dermatology.
    Miyachi Y; Kurosawa M
    Australas J Dermatol; 1998 Feb; 39(1):14-8. PubMed ID: 9529682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells in mastocytosis and allergy - Important player in metabolic and immunological homeostasis.
    Renke J; Kędzierska-Mieszkowska S; Lange M; Nedoszytko B; Wasilewska E; Liberek A; Renke M; Niedoszytko M; Witkowski J; Skórko-Glonek J; Lipińska B
    Adv Med Sci; 2019 Mar; 64(1):124-130. PubMed ID: 30641273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting c-kit in the therapy of mast cell disorders: current update.
    El-Agamy DS
    Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells and inflammation.
    Frenzel L; Hermine O
    Joint Bone Spine; 2013 Mar; 80(2):141-5. PubMed ID: 23116710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy.
    Kinney SR; Carlson L; Ser-Dolansky J; Thompson C; Shah S; Gambrah A; Xing W; Schneider SS; Mathias CB
    PLoS One; 2015; 10(7):e0132467. PubMed ID: 26147007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro functional reactivities of cutaneous mast cells from patients with mastocytosis.
    Tharp MD; Chaker B; Glass MJ; Burton R; Seelig LL
    J Invest Dermatol; 1987 Sep; 89(3):264-8. PubMed ID: 3624898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).
    Conti P; Caraffa A; Ronconi G; Conti CM; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
    Immunol Res; 2018 Jun; 66(3):323-331. PubMed ID: 29907890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell mediators in allergic inflammation and mastocytosis.
    Castells M
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):465-85. PubMed ID: 16931289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
    Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
    Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Mast Cells with Biologics.
    Lyons JJ; Metcalfe DD
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):667-685. PubMed ID: 33012327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human mast cell: an overview.
    Krishnaswamy G; Ajitawi O; Chi DS
    Methods Mol Biol; 2006; 315():13-34. PubMed ID: 16110146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
    Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
    Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.
    Bladergroen BA; Strik MC; Wolbink AM; Wouters D; Broekhuizen R; Kummer JA; Hack CE
    Eur J Immunol; 2005 Apr; 35(4):1175-83. PubMed ID: 15739160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells as targets of pimecrolimus.
    Ma Z; Jiao Z
    Curr Pharm Des; 2011 Nov; 17(34):3823-9. PubMed ID: 22114844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
    Granerus G; Lönnqvist B; Roupe G
    Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of BiRyuChe-bang on mast cell-mediated allergic reactions and inflammatory cytokines production.
    Moon PD; Choi IS; Go JH; Lee BJ; Kang SW; Yoon S; Han SJ; Nam SY; Oh HA; Han NR; Kim YS; Kim JS; Kim MJ; Jeong HJ; Kim HM
    Am J Chin Med; 2013; 41(6):1267-82. PubMed ID: 24228600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
    Butterfield JH; Ravi A; Pongdee T
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells: novel clinical perspectives from recent insights.
    Kneilling M; Röcken M
    Exp Dermatol; 2009 May; 18(5):488-96. PubMed ID: 19382316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders.
    Gotlib J; Akin C
    Semin Hematol; 2012 Apr; 49(2):128-37. PubMed ID: 22449623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.